Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.
How Has The Chronic Liver Diseases Therapeutics Market Size Shifted, And What Is the Outlook Through 2034?
The market size for therapeutics in chronic liver disease has experienced swift expansion in the past few years. The market, projected to expand from $14.38 billion in 2024 to $15.92 billion in 2025, will do so at a Compound Annual Growth Rate (CAGR) of 10.7%. The surge during the historical period may be due to heightened instances of viral hepatitis, rising obesity levels, an older demographic, increased consciousness about liver health, and improved patient accessibility to treatment.
The market size for therapeutics in chronic liver disease is projected to experience substantial growth in the coming years, expanding to $23.83 billion in 2029 with a compound annual growth rate (CAGR) of 10.6%. This growth prediction is attributed to an increased attention towards personalized medicine, enhancement of novel therapy pipelines, widespread use of telemedicine and digital health solutions, and a surge in the demand for programs aimed at preventing liver diseases, along with a heightened occurrence of viral hepatitis. Key emerging trends include the utilization of artificial intelligence in diagnostic procedures, the application of biologics and gene therapies, non-intrusive treatment alternatives, combined therapies, and the broadening of patient-centered care models.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21145&type=smp
What are the Fundamental Drivers and Innovations Shaping the Chronic Liver Diseases Therapeutics Market?
The rise in alcohol consumption is anticipated to fuel the expansion of the chronic liver disease therapeutics market. The consumption of alcoholic beverages, which can vary from moderate to excessive, involves the ingestion of ethanol and carries potential health effects. The escalation in alcohol consumption can be attributed to its growing societal acceptance, increased income levels, and enhanced global accessibility. Chronic liver disease therapeutics are used to regulate liver damage brought about by excessive alcohol use, thereby slowing the progression of disease and enhancing liver function. For example, the First Citizens Bank, a US financial establishment, reported in June 2024 that there was a 1.2% rise in direct-to-consumer (DTC) wine case sales in 2023 compared to the previous year. Furthermore, according to a report published by Kirin Holdings Company Limited, a beverage firm based in Japan, in December 2023, approximately 192.1 million kiloliters of beer were consumed in 2022, denoting a 2.9% increase from the previous year. Consequently, the upswing in alcohol consumption is steering the growth of the chronic liver disease therapeutics market.
How Is the Chronic Liver Diseases Therapeutics Market Segmented?
The chronic liver diseases therapeutics market covered in this report is segmented –
1) By Treatment Type: Antiviral Drugs, Immunosuppressants Vaccines, Immunoglobulins, Corticosteroids, Targeted Therapy, Chemotherapy
2) By Disease Type: Hepatitis, Autoimmune Diseases, Non-Alcoholic Fatty Liver Disease, Cancer, Genetic Disorders
3) By Application: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Antiviral Drugs: Nucleoside Or Nucleotide Analogues, Interferons, Direct-Acting Antivirals
2) By Immunosuppressants: Calcineurin Inhibitors, mTOR Inhibitors, Purine Synthesis Inhibitors
3) By Vaccines: Hepatitis A Vaccine, Hepatitis B Vaccine, Combination Hepatitis Vaccines
4) By Immunoglobulins: Hepatitis B Immune Globulin, Intravenous Immunoglobulin
5) By Corticosteroids: Prednisolone, Methylprednisolone, Dexamethasone
6) By Targeted Therapy: Tyrosine Kinase Inhibitors, Monoclonal Antibodies
7) By Chemotherapy: Systemic Chemotherapy, Transarterial Chemoembolization Agents
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=21145&type=smp
Which Regions Are Driving the Next Phase of the Chronic Liver Diseases Therapeutics Market Growth?
North America was the largest region in the chronic liver diseases therapeutics market in 2024. The regions covered in the chronic liver diseases therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Key Trends Are Shaping the Future of the Chronic Liver Diseases Therapeutics Market?
The main players in the therapeutics market for chronic liver diseases are concentrating their efforts on the development of groundbreaking advancements like RNA therapies. These therapies target specific genetic and molecular mechanisms and offer more effective, tailor-made treatment options. RNA therapies are cutting-edge treatment methods that employ RNA molecules to manage gene expression or the production of proteins. They aim to treat or avoid diseases by honing in on specific genetic processes. An example of this occurred in May 2022 when Ochre Bio, a UK-based biotech entity, established its innovative ‘Liver ICU’ research facility at BioLabs@NYULangone in New York City, a hub for biopharma start-ups. This contemporary site utilizes entire human livers kept on perfusion machines to evaluate the efficiency of next-gen RNA therapeutics. The facility uses rejected donor livers for research in an attempt to expedite the drug development process and enhance the accuracy of liver treatment studies by mimicking human physiological conditions.
View the full report here:
How Is the Chronic Liver Diseases Therapeutics Market Defined and What Are Its Core Parameters?
Chronic liver disease therapeutics refers to the medical treatments and interventions aimed at managing long-term liver conditions. These therapies focus on slowing disease progression, alleviating symptoms, and improving liver function through medications, lifestyle changes, and, in some cases, advanced procedures.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21145
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model